Vanguard Group Inc Cytokinetics Inc Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
369Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$870 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$725 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$387 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$315 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.65MShares$180 Million4.28% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.65B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...